Developer of novel biocatalytic methods intended to discover non-standard technological challenges in biotechnology. The company's platform specializes in biotechnological applications of microorganisms from extreme environments, extremophiles, and bioactive compounds, enabling clients to decide at the end of each research step about the further development and direction of the service.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 04-Jul-2011 | Completed | Startup |
Name | Representing | Role | Since |
---|---|---|---|
Jenny Blamey Ph.D | Swissaustral Biotech | Co-Founder,Chief Scientific Officer,Scientific Director & Board Member | 000 0000 |
Olivier Rickmers | Swissaustral Biotech | Co-Founder,Chief Executive Officer, President & Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Fondation The Ark | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |